A new trading day began on Monday, with AC Immune SA (NASDAQ: ACIU) stock price up 10.46% from the previous day of trading, before settling in for the closing price of $3.25. ACIU’s price has ranged from $1.43 to $3.99 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged -45.82%. With a float of $61.06 million, this company’s outstanding shares have now reached $88.04 million.
AC Immune SA (ACIU) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of AC Immune SA is 38.28%, while institutional ownership is 25.11%. The most recent insider transaction that took place on Oct 03 ’25, was worth 140,850. Before that another transaction happened on Sep 12 ’25, when Company’s Officer proposed sale 35,000 for $2.38, making the entire transaction worth $83,300.
AC Immune SA (ACIU) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of 0.05 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -45.82% per share during the next fiscal year.
AC Immune SA (NASDAQ: ACIU) Trading Performance Indicators
Here are AC Immune SA’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.33. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.58, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.49 in one year’s time.
Technical Analysis of AC Immune SA (ACIU)
The latest stats from [AC Immune SA, ACIU] show that its last 5-days average volume of 0.43 million was superior to 0.18 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 59.05%.
During the past 100 days, AC Immune SA’s (ACIU) raw stochastic average was set at 82.91%, which indicates a significant increase from 82.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.32 in the past 14 days, which was higher than the 0.20 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.69, while its 200-day Moving Average is $2.25. Now, the first resistance to watch is $3.82. This is followed by the second major resistance level at $4.05. The third major resistance level sits at $4.41. If the price goes on to break the first support level at $3.24, it is likely to go to the next support level at $2.88. Assuming the price breaks the second support level, the third support level stands at $2.65.
AC Immune SA (NASDAQ: ACIU) Key Stats
With a market capitalization of 355.21 million, the company has a total of 100,410K Shares Outstanding. Currently, annual sales are 31,020 K while annual income is -57,840 K. The company’s previous quarter sales were 1,580 K while its latest quarter income was -25,690 K.
